Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Leukemia & Lymphoma|October 31, 2006
NY-ESO-1 immunotherapy for multiple myelomaSusann Szmania, Guido Tricot, Frits van Rhee
Blood and Lymphatic Cancer : Targets and Therapy|May 26, 2015
Profile of elotuzumab and its potential in the treatment of multiple myelomaYi-Chang Liu, Susann Szmania, Frits van Rhee
Clinical Advances in Hematology & Oncology : H&O|September 25, 2010
Castleman disease in the 21st century: an update on diagnosis, assessment, and therapyFrits van Rhee, Katie Stone, Susann Szmania, et al.
Vaccine|January 11, 2014
Efficient lysis of epithelial ovarian cancer cells by MAGE-A3-induced cytotoxic T lymphocytes using rAAV-6 capsid mutant vectorRamesh B Batchu, Oksana V Gruzdyn, Amberly M Moreno-Bost, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Immunization with a recombinant MAGE-A3 protein after high-dose therapy for myelomaSusann Szmania, Sacha Gnjatic, Guido Tricot, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 22, 2014
Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patientsSusann Szmania, Natalia Lapteva, Tarun Garg, et al.
Cytotherapy|August 21, 2012
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applicationsNatalia Lapteva, April G Durett, Jiali Sun, et al.
Pageof 2